Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Insights into insulin resistance and type 2 diabetes from knockout mouse models.

× No keyword cloud information.

49 in total

1. Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene.

Authors: L Rossetti; A E Stenbit; W Chen; M Hu; N Barzilai; E B Katz; M J Charron
Journal: J Clin Invest Date: 1997-10-01 Impact factor: 14.808

2. Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans.

Authors: N J Cox; M Frigge; D L Nicolae; P Concannon; C L Hanis; G I Bell; A Kong
Journal: Nat Genet Date: 1999-02 Impact factor: 38.330

3. Disruption of IRS-2 causes type 2 diabetes in mice.

Authors: D J Withers; J S Gutierrez; H Towery; D J Burks; J M Ren; S Previs; Y Zhang; D Bernal; S Pons; G I Shulman; S Bonner-Weir; M F White
Journal: Nature Date: 1998-02-26 Impact factor: 49.962

4. Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1.

Authors: H Abe; N Yamada; K Kamata; T Kuwaki; M Shimada; J Osuga; F Shionoiri; N Yahagi; T Kadowaki; H Tamemoto; S Ishibashi; Y Yazaki; M Makuuchi
Journal: J Clin Invest Date: 1998-04-15 Impact factor: 14.808

5. Lack of insulin receptors affects the formation of white adipose tissue in mice. A morphometric and ultrastructural analysis.

Authors: S Cinti; S Eberbach; M Castellucci; D Accili
Journal: Diabetologia Date: 1998-02 Impact factor: 10.122

6. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.

Authors: A Okuno; H Tamemoto; K Tobe; K Ueki; Y Mori; K Iwamoto; K Umesono; Y Akanuma; T Fujiwara; H Horikoshi; Y Yazaki; T Kadowaki
Journal: J Clin Invest Date: 1998-03-15 Impact factor: 14.808

7. GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes.

Authors: A E Stenbit; T S Tsao; J Li; R Burcelin; D L Geenen; S M Factor; K Houseknecht; E B Katz; M J Charron
Journal: Nat Med Date: 1997-10 Impact factor: 53.440

8. The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family.

Authors: B E Lavan; W S Lane; G E Lienhard
Journal: J Biol Chem Date: 1997-04-25 Impact factor: 5.157

9. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance.

Authors: J C Brüning; M D Michael; J N Winnay; T Hayashi; D Hörsch; D Accili; L J Goodyear; C R Kahn
Journal: Mol Cell Date: 1998-11 Impact factor: 17.970

10. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity.

Authors: S S Deeb; L Fajas; M Nemoto; J Pihlajamäki; L Mykkänen; J Kuusisto; M Laakso; W Fujimoto; J Auwerx
Journal: Nat Genet Date: 1998-11 Impact factor: 38.330

61 in total

1. Unraveling the mechanism of action of thiazolidinediones.

Authors: C R Kahn; L Chen; S E Cohen
Journal: J Clin Invest Date: 2000-12 Impact factor: 14.808

Review 2. Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists.

Authors: J M Olefsky
Journal: J Clin Invest Date: 2000-08 Impact factor: 14.808

3. PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors.

Authors: Toru Akune; Shinsuke Ohba; Satoru Kamekura; Masayuki Yamaguchi; Ung-Il Chung; Naoto Kubota; Yasuo Terauchi; Yoshifumi Harada; Yoshiaki Azuma; Kozo Nakamura; Takashi Kadowaki; Hiroshi Kawaguchi
Journal: J Clin Invest Date: 2004-03 Impact factor: 14.808

Review 4. New insights into the integrated physiology of insulin action.

Authors: Yukari Kitamura; Domenico Accili
Journal: Rev Endocr Metab Disord Date: 2004-05 Impact factor: 6.514

Review 5. Distinct effects of PPARgamma insufficiency on bone marrow cells, osteoblasts, and osteoclastic cells.

Authors: Hiroshi Kawaguchi; Toru Akune; Masayuki Yamaguchi; Shinsuke Ohba; Naoshi Ogata; Ung-il Chung; Naoto Kubota; Yasuo Terauchi; Takashi Kadowaki; Kozo Nakamura
Journal: J Bone Miner Metab Date: 2005 Impact factor: 2.626

6. A Novel Peroxisome Proliferator-activated Receptor (PPAR)α Agonist and PPARγ Antagonist, Z-551, Ameliorates High-fat Diet-induced Obesity and Metabolic Disorders in Mice.

Authors: Yoshihiro Shiomi; Toshimasa Yamauchi; Masato Iwabu; Miki Okada-Iwabu; Ryo Nakayama; Yuki Orikawa; Yoshichika Yoshioka; Koichiro Tanaka; Kohjiro Ueki; Takashi Kadowaki
Journal: J Biol Chem Date: 2015-04-23 Impact factor: 5.157

Review 7. Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis.

Authors: Hideaki Kaneto; Naoto Katakami; Munehide Matsuhisa; Taka-aki Matsuoka
Journal: Mediators Inflamm Date: 2010-02-16 Impact factor: 4.711

8. Complex haplotypes of IRS2 gene are associated with severe obesity and reveal heterogeneity in the effect of Gly1057Asp mutation.

Authors: Corinne Lautier; Samira Ait El Mkadem; Eric Renard; Jean Frédéric Brun; Jean Christophe Gris; Jacques Bringer; Florin Grigorescu
Journal: Hum Genet Date: 2003-04-10 Impact factor: 4.132

9. Peroxisome proliferator-activated receptor gamma is required in mature white and brown adipocytes for their survival in the mouse.

Authors: Takeshi Imai; Reiko Takakuwa; Sandra Marchand; Emilie Dentz; Jean-Marc Bornert; Nadia Messaddeq; Olivia Wendling; Manuel Mark; Béatrice Desvergne; Walter Wahli; Pierre Chambon; Daniel Metzger
Journal: Proc Natl Acad Sci U S A Date: 2004-03-16 Impact factor: 11.205

10. Abnormalities in carbohydrate and lipid metabolisms in high-fructose dietfed insulin-resistant rats: amelioration by Catharanthus roseus treatments.

Authors: Karuna Rasineni; Ramesh Bellamkonda; Sreenivasa Reddy Singareddy; Saralakumari Desireddy
Journal: J Physiol Biochem Date: 2013-01-22 Impact factor: 4.158